|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 14/535 | (2006.01) |
| (11) | Patento numeris | 3381942 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18157842.8 |
| Europos patento paraiškos padavimo data | 2013-08-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261694963 P | 2012-08-30 | US | |
| 201361846147 P | 2013-07-15 | US |
| (72) |
VANDERWALDE, Ari, US
SHABOOTI, Mohamed, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | A METHOD FOR TREATING MELANOMA USING A HERPES SIMPLEX VIRUS AND AN IMMUNE CHECKPOINT INHIBITOR |
| A METHOD FOR TREATING MELANOMA USING A HERPES SIMPLEX VIRUS AND AN IMMUNE CHECKPOINT INHIBITOR |